September 6, 2016 — IBA (Ion Beam Applications S.A.) and RaySearch Laboratories have entered into a long-term strategic alliance to combine their respective technologies and advance adaptive proton therapy.
As part of the collaboration, the RayCare oncology information system, which is currently in development at RaySearch, will be customized for optimal use together with the IBA delivery solutions. In both RayStation and RayCare, as well as in the IBA delivery solutions, joint features, dedicated software interfaces and modified graphical user interface components will allow for a close and seamless workflow integration with optimized performances. The result will be a complete turnkey solution for all software and hardware needed to deliver adaptive proton therapy treatment.
Proton therapy is one of the most precise forms of radiation therapy: Targets can be pinpointed with the optimal radiation dose, while adjacent tissue is spared to a much higher degree than with conventional radiation therapy. The technique is growing in popularity worldwide, and studies are converging to point towards the fact that approximately 20 percent of radiation therapy patients could benefit from proton therapy while only 1 percent receive it today.
For more information: www.raysearchlabs.com, www.iba-worldwide.com
May 03, 2025 
